Tocagen (Tocagen) Current Deferred Taxes Liabilities : $0.00 Mil (As of Mar. 2020)

View and export this data going back to 2017. Start your Free Trial

What is Tocagen Current Deferred Taxes Liabilities?

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Tocagen's current deferred tax liabilities for the quarter that ended in Mar. 2020 was $0.00 Mil.

Tocagen Current Deferred Taxes Liabilities Historical Data

The historical data trend for Tocagen's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tocagen Current Deferred Taxes Liabilities Chart

Tocagen Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Current Deferred Taxes Liabilities

Tocagen Quarterly Data
	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20
Current Deferred Taxes Liabilities	Get a 7-Day Free Trial													-	-	-	-	-

Tocagen Current Deferred Taxes Liabilities Related Terms

Thank you for viewing the detailed overview of Tocagen's Current Deferred Taxes Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Tocagen (Tocagen) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tocagen Inc (NAS:TOCA) » Definitions » Current Deferred Taxes Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

4242 Campus Point Court, Suite 500, San Diego, CA, USA, 92121

Website

http://www.tocagen.com

Tocagen Inc is a clinical-stage, cancer-selective gene therapy company. It is focused on developing product candidates designed to activate a patient's immune system against their own cancer from within. The company's cancer-selective gene therapy platform is built on retroviral replicating vectors, or RRVs, which are designed to selectively deliver therapeutic genes into the DNA of cancer cells. Tocagen is developing product candidate, Toca 511 and Toca FC, for the treatment of recurrent high grade glioma, or HGG, a brain cancer with limited treatment options, low survival rates and, therefore, a significant unmet medical need. Geographically, the activities are carried out through United States.